carbamates has been researched along with Stress Disorders, Post-Traumatic in 8 studies
Stress Disorders, Post-Traumatic: A class of traumatic stress disorders with symptoms that last more than one month.
Excerpt | Relevance | Reference |
---|---|---|
"Similar to clinical PTSD, approximately 25-30% of rats that undergo cued fear conditioning exhibit impaired extinction learning." | 1.56 | Endocannabinoid modulating drugs improve anxiety but not the expression of conditioned fear in a rodent model of post-traumatic stress disorder. ( Diwan, M; Giacobbe, P; Gidyk, DC; Gouveia, FV; Hamani, C; Lipsman, N; Nobrega, JN; Vimalanathan, A, 2020) |
"Posttraumatic stress disorder (PTSD) is a debilitating condition highly comorbid with depression." | 1.48 | Cannabinoids prevent depressive-like symptoms and alterations in BDNF expression in a rat model of PTSD. ( Akirav, I; Burstein, O; Doron, R; Shoshan, N, 2018) |
"It was suggested that in PTSD, hippocampal-dependent memory is compromised while amygdala-dependent memory is strengthened." | 1.46 | Cannabinoids prevent the differential long-term effects of exposure to severe stress on hippocampal- and amygdala-dependent memory and plasticity. ( Abush, H; Akirav, I; Mizrachi Zer-Aviv, T; Segev, A; Shoshan, N, 2017) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 6 (75.00) | 24.3611 |
2020's | 2 (25.00) | 2.80 |
Authors | Studies |
---|---|
Maymon, N | 1 |
Mizrachi Zer-Aviv, T | 3 |
Sabban, EL | 2 |
Akirav, I | 6 |
Vimalanathan, A | 1 |
Gidyk, DC | 1 |
Diwan, M | 1 |
Gouveia, FV | 1 |
Lipsman, N | 1 |
Giacobbe, P | 1 |
Nobrega, JN | 1 |
Hamani, C | 1 |
Aisenberg, N | 1 |
Serova, L | 1 |
Shoshan, N | 2 |
Segev, A | 1 |
Abush, H | 1 |
Morena, M | 1 |
Berardi, A | 1 |
Colucci, P | 1 |
Palmery, M | 1 |
Trezza, V | 1 |
Hill, MN | 1 |
Campolongo, P | 1 |
Burstein, O | 1 |
Doron, R | 1 |
Fidelman, S | 1 |
Lange, R | 1 |
Hillard, CJ | 1 |
Zer-Aviv, TM | 1 |
8 other studies available for carbamates and Stress Disorders, Post-Traumatic
Article | Year |
---|---|
Neuropeptide Y and cannabinoids interaction in the amygdala after exposure to shock and reminders model of PTSD.
Topics: Amygdala; Animals; Arachidonic Acids; Arousal; Basolateral Nuclear Complex; Behavior, Animal; Benzam | 2020 |
Endocannabinoid modulating drugs improve anxiety but not the expression of conditioned fear in a rodent model of post-traumatic stress disorder.
Topics: Animals; Anxiety; Benzamides; Benzoxazines; Carbamates; Conditioning, Psychological; Disease Models, | 2020 |
The effects of enhancing endocannabinoid signaling and blocking corticotrophin releasing factor receptor in the amygdala and hippocampus on the consolidation of a stressful event.
Topics: Amidohydrolases; Animals; Anxiety; Basolateral Nuclear Complex; Benzamides; CA1 Region, Hippocampal; | 2017 |
Cannabinoids prevent the differential long-term effects of exposure to severe stress on hippocampal- and amygdala-dependent memory and plasticity.
Topics: Amidohydrolases; Amygdala; Animals; Avoidance Learning; Benzamides; Benzoxazines; Bromine; Cannabino | 2017 |
Enhancing Endocannabinoid Neurotransmission Augments The Efficacy of Extinction Training and Ameliorates Traumatic Stress-Induced Behavioral Alterations in Rats.
Topics: Amidohydrolases; Animals; Arachidonic Acids; Benzamides; Benzodioxoles; Benzoxazines; Cannabinoid Re | 2018 |
Cannabinoids prevent depressive-like symptoms and alterations in BDNF expression in a rat model of PTSD.
Topics: Amidohydrolases; Animals; Benzamides; Benzoxazines; Brain-Derived Neurotrophic Factor; Cannabinoid R | 2018 |
Chronic treatment with URB597 ameliorates post-stress symptoms in a rat model of PTSD.
Topics: Amidohydrolases; Animals; Arachidonic Acids; Basolateral Nuclear Complex; Benzamides; Benzoxazines; | 2018 |
Sex differences in hippocampal response to endocannabinoids after exposure to severe stress.
Topics: Amidohydrolases; Amygdala; Animals; Benzamides; Carbamates; Disease Models, Animal; Endocannabinoids | 2016 |